Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications - Top-Institutions - MDSpire

Current Evidence and Future Directions of Neoadjuvant Treatments for Clear Cell Renal Cell Carcinoma

  • By

  • Thomas McMaster

  • Niall McVeigh

  • David C. Chen

  • Abdullah Al-Khanaty

  • Kieran Sandhu

  • Jonathon Carll

  • Dixon T. Woon

  • Declan G. Murphy

  • Nathan Lawrentschuck

  • Lewis Au

  • Muhammad Ali

  • Shankar Siva

  • Marlon Perera

  • July 17, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Urology
    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Urology
    • Oncology

  • #3

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, Tennessee

    Key Differentiators

    • Urology
    • Oncology

Original Source(s)

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications

  • by Thomas McMaster, Niall McVeigh, David C. Chen, Abdullah Al-Khanaty, Kieran Sandhu, Jonathon Carll, Dixon T. Woon, Declan G. Murphy, Nathan Lawrentschuck, Lewis Au, Muhammad Ali, Shankar Siva, Marlon Perera

  • July 17, 2026

Related Content

Radiomics and clinical data predict pseudoprogression after radiotherapy in high-grade glioma

Access to molecular diagnostics for CNS tumors through international outsourcing: experience from Jordan

Long-term risk of gynecologic malignancies in postmenopausal women with vaginal bleeding and benign endometrial lesions: a cohort study